Epidemiological studies in the US have suggested an incidence rate of 2 to 3 new cases/100,000 population per year.[6] Because life expectancy appears to be normal in most cases, the prevalence of essential thrombocytosis is several-fold higher than the incidence. 

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer